CANCER INTELLIGENCE LIMITED – Trademark Portfolio
Entity Type: 11
CANCER INTELLIGENCE LIMITED holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ECANCER. The owner is based in Bristol.
Second Floor, 154 Cheltenham Road
Bristol BS65RL , GB
Showing of trademarks Trademarks
Trademark Classifications
CANCER INTELLIGENCE LIMITED's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does CANCER INTELLIGENCE LIMITED have?
CANCER INTELLIGENCE LIMITED has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does CANCER INTELLIGENCE LIMITED file in?
CANCER INTELLIGENCE LIMITED files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.
What are CANCER INTELLIGENCE LIMITED's most well-known trademarks?
CANCER INTELLIGENCE LIMITED's registered trademark portfolio includes well-known marks such as ECANCER. These are among 1 currently registered trademark in the portfolio.
What is CANCER INTELLIGENCE LIMITED's trademark registration success rate?
CANCER INTELLIGENCE LIMITED has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.